SAT0241 Early Response to Belimumab in Sle-Related Joint Involvement Evaluated by Ultrasonographic Assessment

doi 10.1136/annrheumdis-2017-eular.4238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Refractory Autoimmune Hemolytic Anemia in a Pediatric SLE Patient Treated With Belimumab

Annals of Paediatric Rheumatology
2013English

Early Rheumatoid Disease. II. Patterns of Joint Involvement.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1976English

Estimating the Cost-Effectiveness of Belimumab Versus Standard Care for Sle Patients in Hong Kong

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Response To: ‘Assessment of Responsiveness of the Musculoskeletal Component of SLE-DAS in an Independent Cohort’, by Hassan Et Al

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Response of Adrenal to the Medication, Evaluated by Urinary Steroids

Folia Endocrinologica Japonica
1966English

Correction To: Effectiveness, Tolerability, and Safety of Belimumab in Patients With Refractory SLE: A Review of Observational Clinical-Practice-Based Studies

Clinical Reviews in Allergy and Immunology
MedicineAllergyImmunology
2018English

Symmetrical Joint Involvement.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1975English

Joint Involvement in Patients Affected by Systemic Lupus Erythematosus: Application of the Swollen to Tender Joint Count Ratio

Reumatismo
Rheumatology
2015English

Response to the Letter to the Editor, “Depression Not Related to Lower Religious Involvement in Bipolar Disorders?”

Bipolar Disorders
PsychiatryBiological PsychiatryMental Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy